ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IMNM vs SEPN // EV/EBITDA & P/E VALUATION

Immunome Inc. (NASDAQ) VS. Septerna Inc. (NASDAQ) • 15-METRIC TALLY: IMNM 2 — SEPN 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMNM VS. SEPN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IMNM SEPN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -20.70% -14.30 SEPN /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -9.29% 5.19% -14.48 SEPN /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -23.20% 180.00% -203.20 SEPN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 25.03 5.87 +19.16 IMNM /balance-sheet <GO>
Piotroski F-Score Quality 3/9 6/9 -3.00 SEPN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.5 65.2 -25.70 SEPN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.16B $2.11B $47.1M IMNM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IMNM REV SEPN REV IMNM GROSS % SEPN GROSS % IMNM FCF SEPN FCF
FY 2025 $6.9M $46.0M — — -$200.6M $109.7M
FY 2024 $9.0M $1.1M — — -$118.0M -$69.6M
FY 2023 $14.0M $151.0K — — -$7.6M -$38.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMNM // BETA —
SEPN // BETA —